Keisha Maloney, MD
Rheumatology · Covington, GANPI 1992996540
Payments from drug & device makers
Across 598 payments — averaging $19.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$2K
- Johnson & Johnson$1K
- UCB, Inc.$981
- AstraZeneca$732
- GSK$506
- plus $4K from 24 others
What the payments were for
- Food & beverage$11,27096%
- Education$4444%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 122 | $2,155 |
| AbbVie | 103 | $1,890 |
| Johnson & Johnson(3 entities) | 63 | $1,417 |
| UCB, Inc. | 56 | $981 |
| AstraZeneca(2 entities) | 14 | $732 |
| GSK | 26 | $506 |
| Genentech USA, Inc. | 24 | $436 |
| Mallinckrodt Hospital Products Inc. | 20 | $427 |
| Novartis | 23 | $411 |
| Lilly USA, LLC | 20 | $396 |
| Pfizer | 28 | $394 |
| Aurinia Pharma U.S., Inc. | 16 | $288 |
| E.r. Squibb & Sons, L.L.C. | 13 | $281 |
| Sobi, Inc | 10 | $191 |
| Mallinckrodt Enterprises LLC | 11 | $179 |
| Radius Health, Inc. | 7 | $147 |
| Sanofi | 7 | $139 |
| Octapharma USA, Inc. | 5 | $131 |
| Bristol Myers Squibb | 10 | $115 |
| Sanofi-aventis U.S. LLC | 1 | $97 |
| ANI Pharmaceuticals, Inc. | 3 | $85 |
| Boehringer Ingelheim | 3 | $68 |
| Organon | 4 | $56 |
| Antares Pharma, Inc. | 3 | $55 |
| Genentech, Inc. | 1 | $31 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPHNELO$528
How this compares
$11,715 in reported general payments places this provider in the 65th percentile of 177 rheumatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 61 | $423,338 |
| Actemra ActpenTocilizumab | 11 | $64,529 |
| Hydroxychloroquine Sulfate | 228 | $6,703 |
| Leflunomide | 82 | $2,517 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $1,681 |
| Duloxetine Hcl | 88 | $1,310 |
| Celecoxib | 43 | $1,258 |
| MethotrexateMethotrexate Sodium | 113 | $1,234 |
| Gabapentin | 91 | $879 |
| Mycophenolate Mofetil | 17 | $844 |
| Tizanidine Hcl | 51 | $816 |
| Pilocarpine Hcl | 11 | $701 |
| Prednisone | 94 | $542 |
| Tramadol Hcl | 89 | $417 |
| Diclofenac Sodium | 11 | $355 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Covington
- Theresa Lawrence FordLawrenceville$2.9M
- Wambui MachuaAtlanta$1.8M
- Brent FlickingerGainesville$1.6M
- James MossellTifton$1.6M
- Roel QuerubinMarietta$1.5M
- Arezou KhosroshahiAtlanta$1.5M
- Sung LimAtlanta$1.3M
- Gary MyersonAtlanta$1.3M
- Jefrey LiebermanDecatur$761K
- Marta BognarGainesville$719K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.